◀ Back to TNF
PRTN3 — TNF
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *
Text-mined interactions from Literome
Yard et al., Clin Exp Immunol 2002
(Wegener Granulomatosis) :
Human
proteinase 3 can
inhibits LPS mediated
TNF-alpha production through CD14 degradation : lack of influence of antineutrophil cytoplasmic antibodies
Ohlsson et al., Clin Exp Immunol 2005
(Lupus Erythematosus, Systemic...) :
Stimulation of monocytes with
tumour necrosis factor (TNF)-alpha , interferon (IFN)-gamma or LPS did not
result in any increase of
PR3 or elastase transcription, whereas interleukin (IL)-8 transcription was increased 10-fold
Hsieh et al., Clin Rheumatol 2007
:
The spontaneous membrane expression of MPO and
PR3 on PMN could be significantly
increased by lipopolysaccharide (LPS) and
TNF-alpha , but not by IL-8 or GRO-alpha
Ammar et al., Cell Immunol 1993
(HIV Infections) :
In addition,
p29 could not
inhibit the production of IL1 and
TNF alpha by normal adherent cells
Mayet et al., Blood 1993
(Wegener Granulomatosis) :
We were able to show that
tumor necrosis factor-alpha , interleukin-1 alpha/beta, and interferon-gamma
led to an increased
PR-3 expression in the cytoplasm of endothelial cells by performing polymerase chain reaction analysis, Western blot, cyto-enzyme linked immunosorbent assays, and confocal laser scanning microscopy
Mayet et al., Eur J Clin Invest 1997
:
Membrane expressed PR-3 was detected by affinity purified and monoclonal
anti-PR-3 Ab.
Tumour necrosis factor alpha (TNF-alpha) induced membrane expression of PR-3 could be blocked with the RNA synthesis inhibitor actinomycin D, the protein kinase C ( PKC ) and proteinase A ( PKA ) inhibitor staurosporine, the specific PKA inhibitor calphostin C, the c-AMP dependent PKA inhibitor KT5720 and the tyrosine kinase inhibitor genistein in a dose dependent manner ... This effect, however, could be overridden by TNF-alpha stimulation, i.e.
TNF-alpha induced membrane expression of
PR-3 was resistant to down-regulation of PKC